keyword
https://read.qxmd.com/read/38678219/seasonal-meropenem-resistance-in-acinetobacter-baumannii-and-influence-of-temperature-driven-adaptation
#21
JOURNAL ARTICLE
Xiaoxuan Liu, Pu Qin, Hainan Wen, Weigang Wang, Jianhong Zhao
BACKGROUND: Recognition of seasonal trends in bacterial infection and drug resistance rates may enhance diagnosis, direct therapeutic strategies, and inform preventive measures. Limited data exist on the seasonal variability of Acinetobacter baumannii. We investigated the seasonality of A. baumannii, the correlation between temperature and meropenem resistance, and the impact of temperature on this bacterium. RESULTS: Meropenem resistance rates increased with lower temperatures, peaking in winter/colder months...
April 27, 2024: BMC Microbiology
https://read.qxmd.com/read/38678002/development-of-novel-indole-quinoline-hybrid-molecules-targeting-bacterial-proton-motive-force
#22
JOURNAL ARTICLE
Jinbeom Seo, Ji-Hoon Kim, Nayoung Ko, Jihyeon Kim, Kyeongwon Moon, In Su Kim, Wonsik Lee
AIMS: This study aimed to develop an editable structural scaffold for improving drug development including pharmacokinetics and pharmacodynamics of antibiotics by using synthetic compounds derived from a (hetero)aryl-quinoline hybrid scaffold. METHODS AND RESULTS: In this study, 18 CF3-substituted (hetero)aryl-quinoline hybrid molecules were examined for their potential antibacterial activity against Staphylococcus aureus by determining minimal inhibitory concentrations...
April 27, 2024: Journal of Applied Microbiology
https://read.qxmd.com/read/38676856/evolution-control-and-success-of-combination-therapy-with-ampicilin-sulbactam-ceftazidime-avibactam-during-a-carbapenem-resistant-acinetobacter-baumannii-outbreak-in-burn-intensive-care-unit
#23
JOURNAL ARTICLE
Emmanuel Dudoignon, Francois Caméléna, Matthieu Lafaurie, Benjamin Deniau, Maité Chaussard, Maxime Coutrot, Lucie Guillemet, Alexandru Cupaciu, Alexandre Pharaboz, Louis Boutin, Mourad Benyamina, Marc Chaouat, Maurice Mimoun, Manel Merimèche, Alexandre Mebazaa, Benoit Plaud, Béatrice Berçot, François Dépret, Guillaume Mellon
We present our findings on interpatient transmission, epidemic control measures, and the outcomes of a series of ten critically ill burn patients who were either colonized or infected with carbapenem-resistant Acinetobacter baumannii (CRAB). None of the five infected patients achieved clinical cure, and all experienced relapses. Microbiological failure was observed in 40% of the infected patients. The isolated CRAB strains were found to carry blaOXA-23 and armA resistance genes. Despite the lack of clinical cure, all five infected patients survived and were discharged from the Burn Intensive Care Unit...
April 27, 2024: European Journal of Clinical Microbiology & Infectious Diseases
https://read.qxmd.com/read/38676579/-comparison-of-three-different-methods-in-investigating-the-molecular-epidemiology-of-carbapenem-resistant-acinetobacter-baumannii-clinical-isolates
#24
COMPARATIVE STUDY
Gülşen Uluçam Atay, Gülçin Bayramoğlu, İlknur Tosun, Ülkü Ünsal
The aim of the study was to evaluate the relationship between carbapenem-resistant Acinetobacter baumannii isolates carrying oxacillinase-type carbapenemase genes with "international high-risk clones" (IC I, II, and III) by different molecular epidemiological methods and to statistically compare the concordance and discrimination power of the methods. Carbapenem-resistant and moderately susceptible A.baumannii isolates from non-repeating blood cultures of 72 patients were included in the study. The presence of "blaOXA-23 , blaOXA-24 , blaOXA-51 ve blaOXA-58 " genes within OXA-type carbapenemases was detected by polymerase chain reaction (PCR) method and confirmed by DNA sequence analysis...
April 2024: Mikrobiyoloji Bülteni
https://read.qxmd.com/read/38675740/development-and-evaluation-of-an-immunoinformatics-based-multi-peptide-vaccine-against-acinetobacter-baumannii-infection
#25
JOURNAL ARTICLE
Sean Jeffreys, Megan P Tompkins, Jadelynn Aki, Sara B Papp, James P Chambers, M Neal Guentzel, Chiung-Yu Hung, Jieh-Juen Yu, Bernard P Arulanandam
Multi-drug-resistant (MDR) Acinetobacter baumannii is an opportunistic pathogen associated with hospital-acquired infections. Due to its environmental persistence, virulence, and limited treatment options, this organism causes both increased patient mortality and incurred healthcare costs. Thus, prophylactic vaccination could be ideal for intervention against MDR Acinetobacter infection in susceptible populations. In this study, we employed immunoinformatics to identify peptides containing both putative B- and T-cell epitopes from proteins associated with A...
March 27, 2024: Vaccines
https://read.qxmd.com/read/38674589/-acinetobacter-baumannii-a-multidrug-resistant-opportunistic-pathogen-in-new-habitats-a-systematic-review
#26
REVIEW
Omar E Ahuatzin-Flores, Eduardo Torres, Edith Chávez-Bravo
In recent years, humanity has begun to face a growing challenge posed by a rise in the prevalence of antibiotic-resistant bacteria. This has resulted in an alarming surge in fatalities and the emergence of increasingly hard-to-manage diseases. Acinetobacter baumannii can be seen as one of these resilient pathogens due to its increasing prevalence in hospitals, its resistance to treatment, and its association with elevated mortality rates. Despite its clinical significance, the scientific understanding of this pathogen in non-hospital settings remains limited...
March 23, 2024: Microorganisms
https://read.qxmd.com/read/38674392/characteristics-of-the-genetic-spread-of-carbapenem-resistant-acinetobacter-baumannii-in-a-tertiary-greek-hospital
#27
JOURNAL ARTICLE
Martha Papadopoulou, Ioannis Deliolanis, Michalis Polemis, Alkiviadis Vatopoulos, Mina Psichogiou, Panagiota Giakkoupi
Acinetobacter baumannii (Ab) has increasingly been identified as a cause of hospital-acquired infections and epidemics. The rise of carbapenem-resistant Acinetobacter baumannii (CRAB) poses significant challenges in treatment. Nosocomial outbreaks linked to CRAΒ A. baumannii strains have been reported worldwide, including in Greece. This study aimed to analyze the molecular epidemiology trends of multidrug-resistant A. baumannii isolates in a tertiary hospital in Athens, Greece. A total of 43 clinical isolates of extensively drug-resistant (XDRAB), pan-drug-resistant (PDRAB), and CRAB were collected from patients suffering from blood infection, hospitalized between 2016 and 2020 at the internal medicine clinics and the ICU...
April 5, 2024: Genes
https://read.qxmd.com/read/38671748/evaluation-of-different-procedures-for-titanium-dental-implant-surface-decontamination-in-vitro-study
#28
JOURNAL ARTICLE
Ante Jordan, Igor Smojver, Ana Budimir, Dragana Gabrić, Marko Vuletić
Polymicrobial biofilm removal and decontamination of the implant surface is the most important goal in the treatment of periimplantitis. The aim of this study is to evaluate the efficacy of four different decontamination methods for removing Acinetobacter baumannii and Staphylococcus aureus biofilms in vitro. Seventy-five dental implants were contaminated with a bacterial suspension and randomly divided into five groups ( n = 15): the negative control group, which received no treatment; the positive control group, treated with 0...
March 28, 2024: Bioengineering
https://read.qxmd.com/read/38671347/risk-factors-for-bacteremic-pneumonia-and-mortality-28-day-mortality-in-patients-with-acinetobacter-baumannii-bacteremia
#29
JOURNAL ARTICLE
Meng Lan, Kang Dongmei, Shen Guodong, Yao Haifeng, Cui Guofeng, Chen Mengting, Fan Xiaoyun
BACKGROUND: Patients infected with Acinetobacter baumannii (AB) bacteremia in hospital have high morbidity and mortality. We analyzed the clinical characteristics of pneumonia and nonpneumonia-related AB bloodstream infections (AB BSIs) and explored the possible independent risk factors for the incidence and prognosis of pneumonia-related AB BSIs. METHODS: A retrospective monocentric observational study was performed. All 117 episodes of hospital-acquired AB bacteremia sorted into groups of pneumonia-related AB BSIs (n = 45) and nonpneumonia-related AB BSIs (n = 72) were eligible...
April 26, 2024: BMC Infectious Diseases
https://read.qxmd.com/read/38670268/molecular-rapid-diagnostic-testing-for-bloodstream-infections-nanopore-targeted-sequencing-with-pathogen-specific-primers
#30
JOURNAL ARTICLE
Dongsheng Han, Fei Yu, Dan Zhang, Juan Hu, Xuan Zhang, Dairong Xiang, Bin Lou, Yu Chen, Shufa Zheng
BACKGROUND: Nanopore sequencing, known for real-time analysis, shows promise for rapid clinical infection diagnosis but lacks effective assays for bloodstream infections (BSIs). METHODS: We prospectively assessed the performance of a novel nanopore targeted sequencing (NTS) assay in identifying pathogens and predicting antibiotic resistance in BSIs, analyzing 387 blood samples from December 2021 to April 2023. RESULTS: The positivity rate for NTS (69...
April 24, 2024: Journal of Infection
https://read.qxmd.com/read/38670179/characterization-of-g-quadruplex-structures-in-genes-involved-in-survival-and-pathogenesis-of-acinetobacter-baumannii-as-a-potential-drug-target
#31
JOURNAL ARTICLE
Aakriti Singh, Neha Jain, Uma Shankar, Tarun Kumar Sharma, Amit Kumar
Acinetobacter baumannii is a notorious pathogen that commonly thrives in hospital environments and is responsible for numerous nosocomial infections in humans. The burgeoning multi-drug resistance leaves relatively minimal options for treating the bacterial infection, posing a significant problem and prompting the identification of new approaches for tackling the same. This motivated us to focus on non-canonical nucleic acid structures, mainly G-quadruplexes, as drug targets. G-quadruplexes have recently been gaining attention due to their involvement in multiple bacterial and viral pathogenesis...
April 24, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38667169/bactesign-building-a-findable-accessible-interoperable-and-reusable-fair-database-for-universal-bacterial-identification
#32
JOURNAL ARTICLE
Andre Childs, David Chand, Jorge Pereira, Swadeshmukul Santra, Swaminathan Rajaraman
With the increasing incidence of diverse global bacterial outbreaks, it is important to build an immutable decentralized database that can capture regional changes in bacterial resistance with time. Herein, we investigate the use of a rapid 3D printed µbiochamber with a laser-ablated interdigitated electrode developed for biofilm analysis of Pseudomonas aeruginosa , Acinetobacter baumannii and Bacillus subtilis using electrochemical biological impedance spectroscopy (EBIS) across a 48 h spectrum, along with novel ladder-based minimum inhibitory concentration (MIC) stencil tests against oxytetracycline, kanamycin, penicillin G and streptomycin...
April 5, 2024: Biosensors
https://read.qxmd.com/read/38666984/nrx-101-d-cycloserine-lurasidone-is-active-against-drug-resistant-urinary-pathogens-in-vitro
#33
JOURNAL ARTICLE
Michael T Sapko, Michael Manyak, Riccardo Panicucci, Jonathan C Javitt
D-Cycloserine (DCS) is a broad-spectrum antibiotic that is currently FDA-approved to treat tuberculosis (TB) disease and urinary tract infection (UTI). Despite numerous reports showing good clinical efficacy, DCS fell out of favor as a UTI treatment because of its propensity to cause side effects. NRX-101, a fixed-dose combination of DCS and lurasidone, has been awarded Qualified Infectious Disease Product and Fast Track Designation by the FDA. In this study, we tested NRX-101 against the urinary tract pathogens Escherichia coli , Pseudomonas aeruginosa , Klebsiella pneumoniae , and Acinetobacter baumannii in cation-adjusted Mueller-Hinton broth (caMHB) and artificial urine media (AUM)...
March 28, 2024: Antibiotics
https://read.qxmd.com/read/38665829/synthesis-and-biological-evaluation-of-new-naphthalimide-thiourea-derivatives-as-potent-antimicrobial-agents-active-against-multidrug-resistant-staphylococcus-aureus-and-mycobacterium-tuberculosis
#34
JOURNAL ARTICLE
Preeti Rana, Ramulu Parupalli, Abdul Akhir, Deepanshi Saxena, Rahul Maitra, Mohmmad Imran, Pradip Malik, Shaik Mahammad Ghouse, Swanand Vinayak Joshi, Danaboina Srikanth, Y V Madhavi, Arunava Dasgupta, Sidharth Chopra, Srinivas Nanduri
The emergence of antibiotic resistance to S. aureus and M. tuberculosis , particularly MRSA, VRSA, and drug-resistant tuberculosis, poses a serious threat to human health. Towards discovering new antibacterial agents, we designed and synthesized a series of new naphthalimide-thiourea derivatives and evaluated them against a panel of bacterial strains consisting of E. coli , S. aureus , K. pneumoniae , P. aeruginosa , A. baumannii and various mycobacterial pathogens. Compounds 4a, 4l, 4m, 4n, 4q, 9f, 9l, 13a, 13d, 13e, 17a, 17b, 17c, 17d, and 17e demonstrated potent antibacterial activity against S...
April 24, 2024: RSC medicinal chemistry
https://read.qxmd.com/read/38665540/investigation-on-the-substrate-specificity-and-n-substitution-tolerance-of-psef-in-catalytic-transformation-of-pseudaminic-acids-to-cmp-pse-derivatives
#35
JOURNAL ARTICLE
Xing Guo, Yan Chu Cheung, Can Li, Han Liu, Pengfei Li, Sheng Chen, Xuechen Li
Pseudaminic acid (Pse) belongs to a class of bacterial non-2-ulosonic acids, and has been implicated in bacterial infection and immune evasion. Various Pse structures with diverse N -substitutions have been identified in pathogenic bacterial strains like Pseudomonas aeruginosa , Campylobacter jejuni , and Acinetobacter baumannii . In this study, we successfully synthesized three new Pse species, including Pse5Ac7Fo, Pse5Ac7(3 R Hb) and Pse7Fo5(3 R Hb) using chemical methods. Furthermore, we investigated the substrate specificity of cytidine 5'-monophosphate (CMP)-Pse synthetase (PseF), resulting in the production of N -modified CMP-Pse derivatives (CMP-Pses)...
April 24, 2024: Chemical Science
https://read.qxmd.com/read/38665033/prevalence-and-resistance-patterns-of-urinary-tract-infection-in-al-madinah-al-munawarah-saudi-arabia-a-retrospective-study
#36
JOURNAL ARTICLE
Areej A Alhhazmi, Rawan A Alhazmi, Eilaf S Alahmadi, Wafa M Almuallim, Zainab I Aljurfi, Mohammad A Alturkostani
BACKGROUND: Urinary tract infections (UTIs) are among the most common infections and can cause numerous complications of the renal system. This study aimed to assess the prevalence of uropathogens and their antibiotic susceptibility patterns in Al-Madinah Al-Munawarah, Saudi Arabia. METHODS: Data was collected from patients with UTIs presented at King Fahad General Hospital in Al-Madinah Al-Munawarah, Saudi Arabia. In this retrospective cross-sectional study, UTI microbial-causing agents and antimicrobial resistance profiles identified using automated systems, Phoenix and VITEK2, were collected between July 2022 and June 2023...
April 2024: Discovery Medicine
https://read.qxmd.com/read/38663213/evidence-and-antibiotic-resistance-profiles-of-clinical-acinetobacter-calcoaceticus-acinetobacter-baumannii-acb-and-non-acb-complex-members-in-companion-animals-a-2020-2022-retrospective-study
#37
JOURNAL ARTICLE
Anna-Rita Attili, Francesca Paola Nocera, Martina Sisto, Martina Linardi, Francesca Gigli, Victor Ngu Ngwa, Filomena Fiorito, Claudia Cerracchio, Marina C T Meligrana, Eleonora Bonacucina, Vincenzo Cuteri, Luisa De Martino
To evaluate the frequency of Acinetobacter spp., belonging to both Acinetobacter calcoaceticus-baumannii (ACB) and non-ACB complex, and their antibiotic resistance profiles in veterinary medicine, a three-year (2020-2022) retrospective study was carried out on sick companion animals. Epidemiological data from different clinical canine, feline, and equine samples, were acquired. For each strain, MALDI-TOF MS identification and susceptibility to a panel of 11 antibiotics, by Kirby-Bauer and E-test methods, were performed...
April 17, 2024: Comparative Immunology, Microbiology and Infectious Diseases
https://read.qxmd.com/read/38661375/pmrab-the-two-component-system-of-acinetobacter-baumannii-controls-the-phosphoethanolamine-modification-of-lipooligosaccharide-in-response-to-metal-ions
#38
JOURNAL ARTICLE
Noriteru Yamada, Go Kamoshida, Tsukasa Shiraishi, Daiki Yamaguchi, Momoko Matsuoka, Reika Yamauchi, Nana Kanda, Roku Kamioka, Norihiko Takemoto, Yuji Morita, Masahiro Fujimuro, Shin-Ichi Yokota, Kinnosuke Yahiro
UNLABELLED: Acinetobacter baumannii is highly resistant to antimicrobial agents, and XDR strains have become widespread. A. baumannii has developed resistance to colistin, which is considered the last resort against XDR Gram-negative bacteria, mainly caused by lipooligosaccharide (LOS) phosphoethanolamine (pEtN) and/or galactosamine (GalN) modifications induced by mutations that activate the two-component system (TCS) pmrAB . Although PmrAB of A. baumannii has been recognized as a drug resistance factor, its function as TCS, including its regulatory genes and response factors, has not been fully elucidated...
April 25, 2024: Journal of Bacteriology
https://read.qxmd.com/read/38660899/-characteristics-of-drug-resistance-and-biofilm-formation-in-carbapenem-resistant-acinetobacter-baumannii-in-hospitalized-children
#39
JOURNAL ARTICLE
Yun-Yun Li, Hou-Chang Liu, Hai-Ping Wang, Ting-Yi DU, Li Jiang
OBJECTIVES: To study the distribution, drug resistance, and biofilm characteristics of carbapenem-resistant Acinetobacter baumannii (CRAB) isolated from hospitalized children, providing a reference for the prevention and treatment of CRAB infections in hospitalized children. METHODS: Forty-eight CRAB strains isolated from January 2019 to December 2022 were classified into epidemic and sporadic strains using repetitive extragenic palindromic sequence-based polymerase chain reaction...
April 15, 2024: Zhongguo Dang Dai Er Ke za Zhi, Chinese Journal of Contemporary Pediatrics
https://read.qxmd.com/read/38657674/clinical-microbiological-profile-and-treatment-response-to-intraventricular-antibiotics-in-the-management-of-post-neurosurgical-meningitis-a-single-center-experience
#40
JOURNAL ARTICLE
Debajyoti Datta, Arunkumar Sekar, Amir Pasha, Ashis Patnaik, Rabi Narayan Sahu, Sumit Bansal
Introduction Post-Neurosurgical Meningitis (PNM) is a serious medical condition with high mortality and morbidity caused by organisms like Staphylococcus aureus and Gram-negative organisms like Acinetobacter baumannii. Optimum concentration of antibiotics in the cerebrospinal fluid (CSF) to treat these infections are difficult to achieve. Intraventricular antibiotic administration bypasses the blood-brain barrier and can achieve high CSF concentration without causing systemic toxicity. Methods Retrospective review of all patient records were done to identify patients who developed post-neurosurgical meningitis and received intraventricular antibiotic therapy during the period of July 2017 to December 2022...
April 24, 2024: Journal of Neurological Surgery. Part A, Central European Neurosurgery
keyword
keyword
165593
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.